Action Is Needed: Costs Limit MS Patients’ Access to DMTs
A recent survey of more than 6,000Ā multiple sclerosis patients in the United States found that health insurance coverage can decide their access toĀ disease-modifying therapies (DMTs), and that that coverage is worsening, leaving a good numberĀ struggling to be able to pay for their treatment. As an MS patient myself, I find…